T. Rowe Price Associates
OPTR

T. Rowe Price Associates’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

T. Rowe Price Associates’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,466,300
Closed -$31.1M – 2571
2013
Q3 		$31.1M Sell
2,466,300
-2,660,708
-52% -$33.5M 0.01% 966
2013
Q2 		$74.2M Buy
+5,127,008
New +$74.2M 0.02% 659